AP NEWS

Global Generic Drugs Market 2018-2022| Availability of Low-cost Alternatives to Promote Growth| Technavio

July 13, 2018

Technavio has published a new market research report on the global generic drugs market from 2018-2022. (Graphic: Business Wire)

LONDON--(BUSINESS WIRE)--Jul 13, 2018--The global generic drugs market is expected to post a CAGR of more than 10% during the period 2018-2022, according to the latest market research report by .

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180713005478/en/

Technavio has published a new market research report on the global generic drugs market from 2018-2022. (Graphic: Business Wire)

A key factor driving the growth of the market is the availability of low-cost alternatives. Generic drugs are available at a lower cost when compared with branded drugs as generic drug applicants do not have to repeat the animal and clinical studies that were required to demonstrate the safety and effectiveness of brand-name medicines. Generic drug companies do not have to incur high initial drug development costs. Thus, these drugs cost about 85% lesser than their brand-name equivalents.

This market research report on the also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.

This report is available at a USD 1,000 discount for a limited time only:

In this report, Technavio highlights the advent of RPA as one of the key emerging trends in the global generic drugs market:

Global generic drugs market: Advent of RPA

The pharmaceutical companies have been using business process automation technologies such as RPA for R&D and manufacturing. RPA involves the use of software with artificial intelligence and machine learning capabilities to handle high-volume and repeatable tasks. RPA technology involves software that logs into applications, enters data, calculates and completes the necessary tasks, and logs out.

“Several companies are using AI for pharmaceutical R&D and manufacturing as digital robots can perform high-volume and repeatable tasks. The speed at which such digital robots complete the processes involved in manufacturing will allow CROs to execute recurring processes faster. This will lead to increased efficiency,” says a senior analyst at Technavio for research on cardiovascular and metabolic disorders.

Global generic drugs market: Segmentation analysis

This market research report segments the global generic drugs market by application (anti-infectives and CNS) and geography (APAC, EMEA, and the Americas).

Anti-infectives are agents that act against infections either by inhibiting the spread of an infectious agent or by destroying the infectious agent. Anti-infective drugs are required to destroy infectious agents that cause several infections in the human body such as tuberculosis, sepsis, and smallpox.

The Americas led the market in 2017 with close to 41% of the market share, followed by APAC and EMEA respectively. The Americas is expected to dominate the global market throughout the forecast period.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market sizing Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20180713005478/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 07/13/2018 04:38 PM/DISC: 07/13/2018 04:38 PM

http://www.businesswire.com/news/home/20180713005478/en

AP RADIO
Update hourly